September 25th, 2026Melatonin Use Linked to Small REM Sleep Reduction in ChildrenA large propensity-matched study linked outpatient melatonin use to a small reduction in REM sleep in children evaluated for polysomnography.Read more
September 25th, 2026Price, Not Science, Drives Obesity GLP-1 Access: Holly Lofton, MDPrior authorization and compounded drugs remain top obesity care access barriers, says NYU Langone's Holly Lofton, MD. Read more
September 25th, 2026 Reimagining Value-Based Deals Through Risk-Pooling ModelsPanelists say IRA, Most Favored Nation rules and fragmented data are freezing value-based deals for durable one-time therapies.Read more
September 25th, 2026NCCN Concordance Doesn't Guarantee Cancer Drug CoveragePayers say NCCN guideline concordance sets a baseline for cancer coverage, but cost and formulary variation may still limit access.Read more
September 25th, 2026FDA Approves Belzutifan-Lenvatinib Combo for Advanced Kidney CancerFDA approved belzutifan plus lenvatinib for advanced ccRCC after PD-1/PD-L1 therapy, expanding treatment options for those with disease progression.Read more
September 25th, 2026Real-World Data Back Dupilumab's Long-Term Use in Pediatric ADA 3-year registry found dupilumab controlled atopic dermatitis (AD) in most children, though those under 6 years were likelier to stop treatment.Read more
September 25th, 2026Overactive Bladder Predictors in Women Extend Beyond Age, BMIMachine learning identified age, BMI, income, and reproductive factors as key predictors of overactive bladder risk among US women.Read more
September 25th, 2026AJMC® in the Press, September 25, 2026Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.Read more